A Phase III, Randomized, Double Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD For the Treatment of BHeAg-Negative, Chronic Hepatitis B
- Pianko, Stephen (Primary Chief Investigator (PCI))
Project: Research